Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001047469-13-005779
Filing Date
2013-05-09
Accepted
2013-05-09 07:40:59
Documents
13
Period of Report
2013-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q a2215026z10-q.htm 10-Q 281659
2 EX-31.1 a2215026zex-31_1.htm EX-31.1 7797
3 EX-31.2 a2215026zex-31_2.htm EX-31.2 7766
4 EX-32.1 a2215026zex-32_1.htm EX-32.1 4531
5 EX-32.2 a2215026zex-32_2.htm EX-32.2 4502
6 EX-99.1 a2215026zex-99_1.htm EX-99.1 68101
13 G83633MM01I001.JPG g83633mm01i001.jpg GRAPHIC 1997
  Complete submission text file 0001047469-13-005779.txt   4413285

Data Files

Seq Description Document Type Size
7 EX-101.INS vstm-20130331.xml EX-101.INS 400493
8 EX-101.SCH vstm-20130331.xsd EX-101.SCH 70207
9 EX-101.CAL vstm-20130331_cal.xml EX-101.CAL 53145
10 EX-101.DEF vstm-20130331_def.xml EX-101.DEF 299510
11 EX-101.LAB vstm-20130331_lab.xml EX-101.LAB 1047720
12 EX-101.PRE vstm-20130331_pre.xml EX-101.PRE 500360
Mailing Address 215 FIRST STREET SUITE 440 CAMBRIDGE MA 02142
Business Address 215 FIRST STREET SUITE 440 CAMBRIDGE MA 02142 617-252-9300
Verastem, Inc. (Filer) CIK: 0001526119 (see all company filings)

EIN.: 273269467 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-35403 | Film No.: 13826482
SIC: 2834 Pharmaceutical Preparations